FPF
ALPN

FNY Partners Fund’s Alpine Immune Sciences Inc ALPN Stock Holding History

FNY Partners Fund’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,000
Closed -$154K – 740
2017
Q2 		$154K Sell
4,000
-1,000
-20% -$9.58K 0.04% 170
2017
Q1 		$58K Sell
5,000
-2,500
-33% -$25.3K 0.01% 669
2016
Q4 		$67 Buy
+7,500
New +$149K ﹤0.01% 273

Other funds holding ALPN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FNY Partners Fund's ALPN Position: Q3 2017 in Review

FNY Partners Fund sold out of Alpine Immune Sciences Inc (ALPN) in Q3 2017, closing a stake of 4,000 shares — an estimated $154K sold.

FNY Partners Fund first reported a position in ALPN in Q4 2016 and held it in 3 quarters. The position peaked at $154K in Q2 2017. 24 funds tracked by Wall St. Rank hold ALPN as of Q3 2017.

  • FNY Partners Fund reported no remaining Alpine Immune Sciences Inc position as of Q3 2017 after selling out during the quarter.
  • FNY Partners Fund sold 4,000 Alpine Immune Sciences Inc shares in Q3 2017, an estimated $154K.
  • FNY Partners Fund first reported a position in Alpine Immune Sciences Inc in Q4 2016 and held it in 3 quarters.
  • FNY Partners Fund's Alpine Immune Sciences Inc position peaked at $154K in Q2 2017.
  • 24 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2017.

Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.